全文获取类型
收费全文 | 1721篇 |
免费 | 182篇 |
国内免费 | 29篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 147篇 |
妇产科学 | 25篇 |
基础医学 | 225篇 |
口腔科学 | 128篇 |
临床医学 | 207篇 |
内科学 | 342篇 |
皮肤病学 | 49篇 |
神经病学 | 35篇 |
特种医学 | 176篇 |
外科学 | 234篇 |
综合类 | 38篇 |
预防医学 | 103篇 |
眼科学 | 44篇 |
药学 | 76篇 |
中国医学 | 2篇 |
肿瘤学 | 95篇 |
出版年
2023年 | 14篇 |
2022年 | 11篇 |
2021年 | 18篇 |
2020年 | 15篇 |
2019年 | 8篇 |
2018年 | 47篇 |
2017年 | 48篇 |
2016年 | 41篇 |
2015年 | 63篇 |
2014年 | 80篇 |
2013年 | 115篇 |
2012年 | 61篇 |
2011年 | 44篇 |
2010年 | 88篇 |
2009年 | 99篇 |
2008年 | 47篇 |
2007年 | 61篇 |
2006年 | 55篇 |
2005年 | 38篇 |
2004年 | 36篇 |
2003年 | 23篇 |
2002年 | 29篇 |
2001年 | 22篇 |
2000年 | 18篇 |
1999年 | 27篇 |
1998年 | 102篇 |
1997年 | 88篇 |
1996年 | 100篇 |
1995年 | 63篇 |
1994年 | 77篇 |
1993年 | 39篇 |
1992年 | 21篇 |
1991年 | 27篇 |
1990年 | 18篇 |
1989年 | 35篇 |
1988年 | 31篇 |
1987年 | 29篇 |
1986年 | 28篇 |
1985年 | 26篇 |
1984年 | 14篇 |
1983年 | 11篇 |
1982年 | 22篇 |
1981年 | 17篇 |
1980年 | 17篇 |
1979年 | 9篇 |
1978年 | 8篇 |
1977年 | 11篇 |
1976年 | 14篇 |
1975年 | 9篇 |
1966年 | 3篇 |
排序方式: 共有1932条查询结果,搜索用时 15 毫秒
91.
Background
We examined which adaptive coping strategies, referring to the concept of 'locus of disease control', were of relevance for patients with chronic pain conditions, and how they were interconnected with patients' life satisfaction and interpretation of disease. 相似文献92.
93.
KA Bergman JF Meis AM Horrevorts L Monnens 《Acta paediatrica (Oslo, Norway : 1992)》1992,81(9):709-711
Systemic candidiasis with renal involvement is a rare but well-recognized complication during intensive care treatment in very-low-birth-weight infants. We report a term neonate who developed anuria associated with bilateral bezoar formation in the renal pelvis and candidemia. The treatment consisted of placement of a nephrostomy tube in the left kidney, short-term irrigation with amphotericin B and iv, and later, oral administration of fluconazole. 相似文献
94.
95.
AM Boot J Nauta AC Hokken-Koelega HA Pols MA de Ridder SM de Muinck Keizer-Schrama 《Archives of disease in childhood》1995,72(6):502-506
A cross sectional study assessed the bone mineral density (BMD) of 20 young adult patients who received a renal transplantation in childhood. The BMD of the lumbar spine, mainly trabecular bone, and of the total body, mainly cortical bone, were measured and expressed as an SD score. Fourteen patients (70%) had a BMD SD score of the lumbar spine below -1, of whom six patients were below -2. Fifteen patients (75%) had a BMD SD score of the total body below -1, of whom seven patients were below -2, Both trabecular and cortical bone appeared to be involved in the osteopenic process. The cumulative dose of prednisone was inversely correlated to both lumbar spine and total body BMD SD score. In a multiple regression analysis the cumulative dose of prednisone appeared to be the only factor with a significant effect on BMD SD score. Most young adult patients who had received a renal transplantation in childhood had moderate to severe osteopenia. Corticosteroid treatment played a major part in the development of osteopenia in these patients. 相似文献
96.
97.
Bays H 《Expert opinion on investigational drugs》2002,11(11):1587-1604
Ezetimibe is a cholesterol absorption inhibitor that significantly lowers low- density lipoprotein cholesterol (LDL-C), and favourably affects triglyceride and high-density lipoprotein cholesterol blood levels in monotherapy and in combination with statins. Hepatic and extrahepatic (peripheral) cholesterol synthesis are well-known sources of cholesterol found in LDL-C. However, the emergence of ezetimibe has highlighted intestinal cholesterol absorption as an additional, important source of cholesterol in LDL-C, and has better illuminated how genetic factors, dietary content, pharmaceutical agents, and nuclear receptor activation (such as liver X receptors) all influence the relative contribution of these important cholesterol sources to LDL-C. In fact, investigations into ezetimibe have sometimes challenged existing scientific dogma, has prompted reconsideration of older data, and has helped create 'new' paradigms in cholesterol metabolism. Thus, ezetimibe's efficacy, excellent tolerability, and safety has not only expanded potential treatment options for dyslipidaemic patients, but also has promoted exploration of new frontiers of lipid research towards a better understanding of cholesterol metabolism. 相似文献
98.
99.
100.